(Q33776149)

29 July 2017

1 reference

title

Live attenuated AIDS viruses as vaccines: promise or peril? (English)

1 reference

29 July 2017

1 reference

Ruprecht RM

1

1 reference

29 July 2017

publication date

1 August 1999

1 reference

29 July 2017

published in

Immunological Reviews

1 reference

29 July 2017

volume

170

1 reference

29 July 2017

page(s)

135-149

1 reference

Importance of the nef gene for maintenance of high virus loads and for development of AIDS

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Protection from pathogenic SIVmac challenge following short-term infection with a nef-deficient attenuated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Importance of the intracytoplasmic domain of the simian immunodeficiency virus (SIV) envelope glycoprotein for pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

A candidate live inactivatable attenuated vaccine for AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Macaques infected with attenuated simian immunodeficiency virus resist superinfection with virulence-revertant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Long-term symptomless HIV-1 infection in recipients of blood products from a single donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Long–term protection against SIV–induced disease in macaques vaccinated with a live attenuated HIV–2 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Weakened SIV vaccine still kills

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Live attenuated AIDS vaccines: hazards and hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1999.TB01335.X

10.1111/J.1600-065X.1999.TB01335.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference